T-Wave Alternans Detection in Implantable Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring T-wave alternans (TWAs) in medical devices require extensive memory usage due to sampling the entire T-wave morphology, leading to inefficient data storage and processing, particularly in implantable medical devices (IMDs) with limited memory capacity.
Innovation Solution
The described techniques optimize memory usage by sampling the EGM signal at a predetermined interval after a fiducial point, such as the QRS complex, and processing T-wave amplitude values to determine TWA values, using either time or frequency domain analysis, allowing for efficient storage and computation of TWA values, and adjusting sampling intervals based on heart rate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If the entire T-wave morphology is sampled at a high rate, then measurement precision of TWA is improved, but memory usage increases
Solution Approach 1:
The patent extracts only the essential information needed for TWA detection by sampling the EGM signal at specific predetermined intervals after fiducial points (such as QRS complexes) rather than continuously sampling the entire T-wave morphology. This selective extraction of critical data points maintains TWA measurement precision while dramatically reducing the quantity of stored data
Solution Approach 2:
Instead of storing complete T-wave morphologies, the patent creates simplified representations by storing only discrete amplitude values at predetermined time intervals. These sampled points serve as sufficient copies for TWA analysis, eliminating the need to store redundant waveform data
2Measurement precision
If more T-wave samples per beat are stored, then measurement precision of TWA is improved, but device complexity increases
Solution Approach 1:
The patent segments the T-wave analysis into discrete time intervals by sampling at predetermined points after fiducial events. This segmentation transforms the continuous waveform analysis into discrete point comparisons, simplifying the processing architecture while maintaining detection precision through strategic sampling locations
3Measurement precision
If the EGM signal is sampled over many beats, then measurement precision of TWA is improved, but loss of time increases
Solution Approach 1:
The patent prepares for efficient TWA detection by establishing predetermined sampling intervals and fiducial point references in advance. This preliminary structuring allows the device to immediately begin accurate TWA measurement upon detecting fiducial events, eliminating the need for complex real-time waveform alignment and reducing the time required to accumulate sufficient measurement data
Data Source
AI summary
An implantable medical device (IMD), such as an implantable pacemaker, cardioverter, or diagnostic device, generates an EGM signal, e.g., a far field EGM signal, samples the EGM signal to obtain a single T-wave amplitude value for each T-wave over a plurality of beats, and stores the T-wave amplitude values in memory. The IMD creates a time series of the T-wave amplitude values stored in memory, calculates the power spectral density for the times series, and selects a power spectral density of a particular frequency, e.g., 0.5 cycles per beat, as the TWA value. The IMD may periodically determine TWA values for the patient and store the values in memory. The TWA values may be presented to medical personnel, e.g., as a trend. The IMD may deliver or modify therapy, or provide an alert, based on the TWA values.